prednisolone has been researched along with Mast-Cell Sarcoma in 8 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Mast-Cell Sarcoma: A unifocal malignant tumor that consists of atypical pathological MAST CELLS without systemic involvement. It causes local destructive growth in organs other than in skin or bone marrow.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taylor, F | 1 |
| Gear, R | 1 |
| Hoather, T | 1 |
| Dobson, J | 1 |
| Trumel, C | 1 |
| Bourgès-Abella, N | 1 |
| Touron, C | 1 |
| Lanore, D | 1 |
| Geffré, A | 1 |
| Diquelou, A | 1 |
| Guelfi, JF | 1 |
| Braun, JP | 1 |
| Dunn, K | 1 |
| Takahashi, T | 1 |
| Kadosawa, T | 1 |
| Nagase, M | 1 |
| Mochizuki, M | 1 |
| Matsunaga, S | 1 |
| Nishimura, R | 1 |
| Sasaki, N | 1 |
| Gerritsen, RJ | 1 |
| Teske, E | 1 |
| Kraus, JS | 1 |
| Rutteman, GR | 1 |
| Naganobu, K | 1 |
| Ogawa, H | 1 |
| Uchida, K | 1 |
| Yamaguchi, R | 1 |
| Ohashi, F | 1 |
| Kubo, K | 1 |
| Aoki, M | 1 |
| Kuwamura, M | 1 |
| Ogawa, Y | 1 |
| Matsuyama, K | 1 |
| Guenther, PP | 1 |
| Huebner, A | 1 |
| Sobottka, SB | 1 |
| Neumeister, V | 1 |
| Weissbach, G | 1 |
| Todt, H | 1 |
| Parwaresch, R | 1 |
| Kalbhen, DA | 1 |
| Wisgens, D | 1 |
| Domenjoz, R | 1 |
8 other studies available for prednisolone and Mast-Cell Sarcoma
| Article | Year |
|---|---|
Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined | 2009 |
Adverse haematological effects of vinblastine, prednisolone and cimetidine treatment: a retrospective study in fourteen dogs with mast cell tumours.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; | 2005 |
What is your diagnosis? Mast cell sarcoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cyclophosphamide; Diagnosis | 1997 |
Inhibitory effects of glucocorticoids on proliferation of canine mast cell tumor.
Topics: Animals; Apoptosis; Cell Division; Dexamethasone; Dog Diseases; Dogs; Glucocorticoids; Intestinal Ne | 1997 |
Multi-agent chemotherapy for mast cell tumours in the dog.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dog Diseases; Dogs; Doxor | 1998 |
Mast cell tumor in the nasal cavity of a dog.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide | 2000 |
Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiatio | 2001 |
[Effect of small doses of anti-inflammatory agents on sulfate-S35 incorporation and cell proliferation of neoplastic mast cells in vitro].
Topics: Amides; Anti-Inflammatory Agents; Butyrates; Cell Division; Chloroquine; Culture Techniques; Dinitro | 1970 |